Literature DB >> 25884207

Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.

Ciara M Shaver1, Brandon S Grove1, Nathan D Putz1, Jennifer K Clune1, William E Lawson1,2, Robert H Carnahan3, Nigel Mackman4, Lorraine B Ware1,5, Julie A Bastarache1.   

Abstract

Tissue factor (TF) initiates the extrinsic coagulation cascade in response to tissue injury, leading to local fibrin deposition. Low levels of TF in mice are associated with increased severity of acute lung injury (ALI) after intratracheal LPS administration. However, the cellular sources of the TF required for protection from LPS-induced ALI remain unknown. In the current study, transgenic mice with cell-specific deletions of TF in the lung epithelium or myeloid cells were treated with intratracheal LPS to determine the cellular sources of TF important in direct ALI. Cell-specific deletion of TF in the lung epithelium reduced total lung TF expression to 39% of wild-type (WT) levels at baseline and to 29% of WT levels after intratracheal LPS. In contrast, there was no reduction of TF with myeloid cell TF deletion. Mice lacking myeloid cell TF did not differ from WT mice in coagulation, inflammation, permeability, or hemorrhage. However, mice lacking lung epithelial TF had increased tissue injury, impaired activation of coagulation in the airspace, disrupted alveolar permeability, and increased alveolar hemorrhage after intratracheal LPS. Deletion of epithelial TF did not affect alveolar permeability in an indirect model of ALI caused by systemic LPS infusion. These studies demonstrate that the lung epithelium is the primary source of TF in the lung, contributing 60-70% of total lung TF, and that lung epithelial, but not myeloid, TF may be protective in direct ALI.

Entities:  

Keywords:  acute respiratory distress syndrome; alveolar capillary barrier permeability; coagulation; fibrin; pulmonary

Mesh:

Substances:

Year:  2015        PMID: 25884207      PMCID: PMC4742948          DOI: 10.1165/rcmb.2014-0179OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  48 in total

Review 1.  Inflammation and coagulation.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

2.  Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.

Authors:  J A Bastarache; T Koyama; N E Wickersham; L B Ware
Journal:  J Immunol Methods       Date:  2014-04-21       Impact factor: 2.303

Review 3.  Tissue factor-integrin interactions in cancer and thrombosis: every Jack has his Jill.

Authors:  B Kocatürk; H H Versteeg
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 4.  Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury.

Authors:  Ciara M Shaver; Julie A Bastarache
Journal:  Clin Chest Med       Date:  2014-09-23       Impact factor: 2.878

5.  Monoclonal antibodies to DIPA: a novel binding partner of p120-catenin isoform 1.

Authors:  Nicholas O Markham; Tracy Cooper; Matthew Goff; Erin M Gribben; Robert H Carnahan; Albert B Reynolds
Journal:  Hybridoma (Larchmt)       Date:  2012-08

6.  Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice.

Authors:  Rafal Pawlinski; Jian-Guo Wang; A Phillip Owens; Julie Williams; Silvio Antoniak; Michael Tencati; Thomas Luther; Jesse W Rowley; Elizabeth N Low; Andrew S Weyrich; Nigel Mackman
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

7.  Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress.

Authors:  Julie A Bastarache; Sara C Sebag; Jennifer K Clune; Brandon S Grove; William E Lawson; David R Janz; L Jackson Roberts; Ryszard Dworski; Nigel Mackman; Lorraine B Ware
Journal:  Thorax       Date:  2012-10-02       Impact factor: 9.139

Review 8.  Tissue factor non-coagulant signaling - molecular mechanisms and biological consequences with a focus on cell migration and apoptosis.

Authors:  M Åberg; A Siegbahn
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

9.  Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.

Authors:  Julie A Bastarache; Richard D Fremont; Jonathan A Kropski; Frederick R Bossert; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-21       Impact factor: 5.464

10.  Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury.

Authors:  Jorrit J Hofstra; Alexander D Cornet; Paul J Declerck; Barry Dixon; Hamid Aslami; Alexander P J Vlaar; Joris J Roelofs; Tom van der Poll; Marcel Levi; Marcus J Schultz
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more
  20 in total

Review 1.  Anticoagulant therapy in acute respiratory distress syndrome.

Authors:  Marta Camprubí-Rimblas; Neus Tantinyà; Josep Bringué; Raquel Guillamat-Prats; Antonio Artigas
Journal:  Ann Transl Med       Date:  2018-01

2.  ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model.

Authors:  Colin F Greineder; Ian H Johnston; Carlos H Villa; Kandace Gollomp; Charles T Esmon; Douglas B Cines; Mortimer Poncz; Vladimir R Muzykantov
Journal:  Blood Adv       Date:  2017-08-08

3.  An Inhaled Inhibitor of Myristoylated Alanine-Rich C Kinase Substrate Reverses LPS-Induced Acute Lung Injury in Mice.

Authors:  Qi Yin; Shijing Fang; Joungjoa Park; Anne L Crews; Indu Parikh; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2016-11       Impact factor: 6.914

4.  GBT1118, a compound that increases the oxygen affinity of hemoglobin, improves survival in murine hypoxic acute lung injury.

Authors:  Nathan D Putz; Ciara M Shaver; Kobina Dufu; Chien-Ming Li; Qing Xu; Athiwat Hutchaleelaha; Josh Lehrer-Graiwer; Susan M Majka; Lorraine B Ware; Julie A Bastarache
Journal:  J Appl Physiol (1985)       Date:  2017-12-14

5.  Viable Allogeneic Mitochondria Transplantation Improves Gas Exchange and Alveolar-Capillary Permeability in Rats with Endotoxin-Induced Acute Lung Injuries.

Authors:  Yu-Li Pang; Shi-Yuan Fang; Tzu-Ting Cheng; Chien-Chi Huang; Ming-Wei Lin; Chen-Fuh Lam; Kuen-Bao Chen
Journal:  Int J Med Sci       Date:  2022-06-06       Impact factor: 3.642

6.  Endothelial cell-specific anticoagulation reduces inflammation in a mouse model of acute lung injury.

Authors:  Jian Lou; Yue Hu; Min-Dan Wu; Luan-Qing Che; Yin-Fang Wu; Yun Zhao; Bao-Ping Tian; Zheng-Qiang Bao; Chen Zhu; Yan-Ping Wu; Lu-Lu He; Chun-Xue Bai; Jian Zhou; Song-Min Ying; Wen Li; Zhi-Hua Chen; Da-Xin Chen; Anthony Dorling; Hua-Hao Shen
Journal:  Acta Pharmacol Sin       Date:  2018-11-16       Impact factor: 6.150

7.  Cell-free hemoglobin: a novel mediator of acute lung injury.

Authors:  Ciara M Shaver; Cameron P Upchurch; David R Janz; Brandon S Grove; Nathan D Putz; Nancy E Wickersham; Sergey I Dikalov; Lorraine B Ware; Julie A Bastarache
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-15       Impact factor: 5.464

8.  Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice.

Authors:  S Antoniak; K Tatsumi; Y Hisada; J J Milner; S D Neidich; C M Shaver; R Pawlinski; M A Beck; J A Bastarache; N Mackman
Journal:  J Thromb Haemost       Date:  2016-04-05       Impact factor: 5.824

9.  Myeloid tissue factor does not modulate lung inflammation or permeability during experimental acute lung injury.

Authors:  Ciara M Shaver; Brandon S Grove; Jennifer K Clune; Nigel Mackman; Lorraine B Ware; Julie A Bastarache
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

10.  Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspiration-induced acute lung injury.

Authors:  J B Kral-Pointner; W C Schrottmaier; V Horvath; H Datler; L Hell; C Ay; B Niederreiter; B Jilma; J A Schmid; A Assinger; N Mackman; S Knapp; G Schabbauer
Journal:  J Thromb Haemost       Date:  2017-06-20       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.